DHA Remote Patient Monitoring (RPM) Reverse Industry Day Announcement

Application for the event is live! Please e-mail Captain Terry Houston at Dha.ncr.healthare-ops.mbx.dha-vh-market-vendors@health.mil, and Kenneth McCright (Contracting Officer) at Kenneth.r.mccright.civ@health.mil to apply for this event.

As part of Market Research, the DHA Virtual Health Branch plans to conduct a Virtual Reverse Industry Day to research Remote Patient Monitoring (RPM) commercial capabilities for potential use within the Military Health System (MHS).

The MHS will use RPM as a tool to help our health care teams monitor, report, and analyze their patient’s acute or chronic conditions from outside the hospital or clinic setting. During this event, DHA is interested in learning about relevant RPM capabilities, whether provided by single vendors or vendor collaborations, provided the vendor(s) is (are) able to provide a product or service that satisfies some or all of the following business requirements:

• Ability to remotely monitor patients outside conventional clinical settings.
• Ability to capture biometric health data through use of wired or wireless peripheral measurement devices (such devices may include, but are not limited to, devices that measure peripheral body temperature, blood pressure, heart rate, weight, activity level, pulse oxygenation, blood glucose level, 1- or 2-lead ECG, balance/falls, wound/incision monitoring, and spirometry/respiratory capacity).
• There is interest in home-based sleep apnea assessment and treatment refinement. However, it is understood that this might necessitate additional patient-end, server, and display platforms. In this case, compatibility of interfaces between the core and sleep apnea systems will be important.
• Ability to capture patient self-report data, in the form of symptom reporting, assessments and questionnaires, reporting on self-care, and other matters, in a simple to use, convenient, and secure format, and to transmit this information to supporting servers in a flexible and secure manner.
• Ability to securely pass biometric and self-report data to centrally managed care management dashboards.
• Ability to display data for up to 100 patients on care management dashboards. Care management dashboards can be adjusted to display targeted biometric and/or self-report data. Top level display can be in summary form, with the ability to “drill down” to greater detail.
• Care management dashboards will have the ability to pass patient biometric and self-report data through to the patient’s Electronic Health Record (EHR), whether that EHR is based upon the AHLTA/CHCS, AHLTA-T, or GENESIS/Millennium platforms.
• Care management dashboards will have the ability to draw and display select patient demographic, diagnostic, or other relevant data from the patient’s EHR.
• Care management dashboards will have the ability to apply risk stratification logic, based upon a combination of biometric and self-report monitoring data, and data drawn from the patient’s EHR (e.g., diagnosis, age, comorbidities, previous hospitalizations for same diagnosis, etc.). Using this risk stratification logic, the care management dashboard will assign patients to high, medium, or low risk categories. Risk stratification logic and thresholds can be adjusted to meet individual patient needs. The dashboard will alert on its care coordinator interface for high-risk patients and will pass this alert to the patient’s EHR and, via secure messaging, to designated members of the patient’s care team.
• Ability to integrate and modify clinical workflows and care plans.
• Patient end, server, and dashboards are easily adjustable/interchangeable to permit management of multiple disease states. If different systems are utilized to cover certain disease states, they share common end-user interfaces for patients and care coordinators, such that a minimum of adaptation is necessary to move between disease states for monitoring.
• Availability of secure bidirectional messaging between patient, care coordinator, and care team.
• Capable of sending prompts or notifications to patient and care team based on specific disease management protocols (examples include prompting care team for outlying physiologic data points or instances of missed data capture).

This event will take place 8 December 2022 with follow-up meeting invites to be sent out at a later date. The reverse industry day event will allow industry partners the opportunity to present capabilities and perspectives in the areas of RPM. Participating vendors will be expected to brief government personnel and demonstrate how their capabilities align to the requirements stated above. A Q&A chat will be available throughout the event. Interested parties should look for a follow-up to this notice that will include a detailed agenda and additional event information. Briefings will be scheduled, with industry presenters participating only during their assigned timeslots. All briefings and discussions will be conducted at the unclassified level.

Depending on the number of interested vendor responses, the Government reserves the right to hold further exchanges with all, some or none of the respondents, depending on the administrative burden and the Government’s needs.

Please direct any questions to dha.ncr.healthare-ops.mbx.dha-vh-market-vendors@health.mil and Kenneth.r.mccright.civ@health.mil and include “8 December 2022 Defense Health Agency (DHA) Virtual Health Branch Reverse Industry Day Vendor Question - [Insert Company Name]” in the subject line. Do not include any procurement sensitive, controlled unclassified, or classified information in submitted questions. DHA may not answer all submitted questions before, or during, the event.

Please ensure to also complete and email a copy of the Vendor Information Form, located in the attachments section of this announcement.